Back to MW MARSHALL WACE, LLP

RLMDRLMD
Showing 7 of 12 quarters

Position history for MWMARSHALL WACE, LLP's holdings in RELMADA THERAPEUTICS INC

MARSHALL WACE, LLP holds 2.2M shares of RLMD (RELMADA THERAPEUTICS INC), worth $15.5M as of 2026-Q2. The position was decreased (-49.9% shares). RLMD represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$15.5M

Current Shares

2.2M

Total Value Change

+$15.4M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.2M
-49.9%
$15.5M0.0%$6.92
0
2026-Q1
Increased
4.5M
+40.5%
$31.2M0.0%$4.67
38
2025-Q4
Increased
3.2M
+1072.4%
$15.4M0.0%$4.53
45
2025-Q3
Increased
272,053
+76.0%
$546,8270.0%$1.88
37
2025-Q2
New
154,568
-
$92,7410.0%$0.61
30
2024-Q4
Exited
0
-100.0%
$00.0%$0.46
0
2024-Q3
Decreased
50,570
-67.7%
$163,8470.0%$3.37
0

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used